GlaxoSmithKline (GSK)

52.70 +0.49  +0.94%  May 21, 2:04PM
Add to Watchlists Create an Alert

GlaxoSmithKline PE Ratio TTM:

19.70 for May 21, 2013
View Full Chart

GlaxoSmithKline PE Ratio TTM Chart

    GlaxoSmithKline Historical PE Ratio TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 44   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    May 21, 2013 19.70
    May 20, 2013 19.51
    May 17, 2013 19.52
    May 16, 2013 19.48
    May 15, 2013 19.61
    May 14, 2013 19.33
    May 13, 2013 19.31
    May 10, 2013 19.29
    May 9, 2013 18.95
    May 8, 2013 18.99
    May 7, 2013 19.15
    May 6, 2013 19.07
    May 3, 2013 19.15
    May 2, 2013 19.22
    May 1, 2013 19.25
    April 30, 2013 19.30
    April 29, 2013 19.59
    April 26, 2013 19.50
    April 25, 2013 19.36
    April 24, 2013 19.19
    April 23, 2013 19.11
    April 22, 2013 18.93
    April 19, 2013 18.85
    April 18, 2013 18.83
    April 17, 2013 18.81
       
    April 16, 2013 18.46
    April 15, 2013 18.40
    April 12, 2013 18.12
    April 11, 2013 18.13
    April 10, 2013 17.85
    April 9, 2013 17.69
    April 8, 2013 17.59
    April 5, 2013 17.49
    April 4, 2013 17.56
    April 3, 2013 17.56
    April 2, 2013 17.56
    April 1, 2013 17.53
    March 28, 2013 16.12
    March 27, 2013 15.94
    March 26, 2013 15.81
    March 25, 2013 15.93
    March 22, 2013 15.96
    March 21, 2013 15.82
    March 20, 2013 15.77
    March 19, 2013 15.73
    March 18, 2013 15.51
    March 15, 2013 15.57
    March 14, 2013 15.54
    March 13, 2013 15.34
    March 12, 2013 15.35

    About Price to Earnings Ratio

    The price to earnings ratio (PE Ratio) is the measure of the share price relative to the annual net income earned by the firm per share. PE ratio shows current investor demand for a company share. A high PE ratio generally indicates increased demand because investors anticipate earnings growth in the future. The PE ratio has units of years, which can be interpreted as the number of years of earnings to pay back purchase price.

    PE ratio is often referred to as the "multiple" because it demonstrates how much an investor is willing to pay for one dollar of earnings. PE Ratios are sometimes calculated using estimations of next year's earnings per share in the denominator. When this happens, it is usually noted.
    Learn More

    Get data for

    GSK PE Ratio TTM Benchmarks

    Companies
    Merck 23.12
    AstraZeneca 11.42
    Eli Lilly and Company 13.20

    GSK PE Ratio TTM Rankings

    Overall 78th percentile
    1737 of 8002
    Sector 84th percentile
    109 of 684 in Healthcare
    Industry 77th percentile
    12 of 54 in Drug Manufacturers - Major

    GSK PE Ratio TTM Range, Past 5 Years

    Minimum 8.468 Mar 9 2009
    Maximum 40.58 Jan 4 2011
    Average 16.56